Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, View ORCID ProfileSharifa Nasreen, Peter C. Austin, Kevin A. Brown, Deshayne B. Fell, Jonathan Gubbay, Kevin L. Schwartz, Mina Tadrous, Kumanan Wilson, Jeffrey C Kwong Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators
doi: https://doi.org/10.1101/2022.10.31.22281766
Ramandip Grewal
1Public Health Ontario, Toronto, Ontario, Canada
PhDLena Nguyen
2ICES, Toronto, Ontario, Canada
MScSarah A Buchan
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
PhDSarah E Wilson
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
MDSharifa Nasreen
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
PhDPeter C. Austin
2ICES, Toronto, Ontario, Canada
5Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
PhDKevin A. Brown
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
PhDDeshayne B. Fell
2ICES, Toronto, Ontario, Canada
6School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
7Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
PhDJonathan Gubbay
1Public Health Ontario, Toronto, Ontario, Canada
8Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
MBBS MScKevin L. Schwartz
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
MD MScMina Tadrous
2ICES, Toronto, Ontario, Canada
9Women’s College Hospital, Toronto, ON, Canada
10Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
PharmD PhDKumanan Wilson
11Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
12Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
13Bruyere Research Institute, Ottawa, Ontario, Canada
MD, MScJeffrey C Kwong
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
14Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
15University Health Network, Toronto, Ontario, Canada
MD MScData Availability
Data sharing agreement The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., healthcare organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet prespecified criteria for confidential access, available at www.ices.on.ca/DAS (email: das{at}ices.on.ca). The full dataset creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely upon coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification.
Posted November 01, 2022.
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, Sharifa Nasreen, Peter C. Austin, Kevin A. Brown, Deshayne B. Fell, Jonathan Gubbay, Kevin L. Schwartz, Mina Tadrous, Kumanan Wilson, Jeffrey C Kwong
medRxiv 2022.10.31.22281766; doi: https://doi.org/10.1101/2022.10.31.22281766
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, Sharifa Nasreen, Peter C. Austin, Kevin A. Brown, Deshayne B. Fell, Jonathan Gubbay, Kevin L. Schwartz, Mina Tadrous, Kumanan Wilson, Jeffrey C Kwong
medRxiv 2022.10.31.22281766; doi: https://doi.org/10.1101/2022.10.31.22281766
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12807)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1200)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)